Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

"We were both barely functional. I even wondered if we were having simultaneous heart failure," Debra DeAngelo told Newsweek.

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

The overall level of respiratory disease in the U.S. that includes COVID, flu, and RSV remains “very low.” Emergency room ...

Are you tired of hearing and thinking, let alone worrying about, COVID? I’ll bet you are. As much as we want to be done with ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...

Older adults hospitalized for respiratory syncytial virus (RSV) face an elevated risk of developing heart failure and a dangerous heart rhythm problem, a Canadian study found.

A Canadian study highlights the elevated risks of heart failure and arrhythmia in older adults hospitalized for RSV, even ...